logo
US Treasury to Sell a Record $100 Billion of Four-Week Bills

US Treasury to Sell a Record $100 Billion of Four-Week Bills

Bloomberg6 hours ago
The US government plans to borrow $100 billion in a single Treasury debt sale this week, an unprecedented figure that showcases both the magnitude of its borrowing needs and its ability to attract investors.
The Treasury said on Tuesday that it will auction $100 billion of four-week bills on Thursday, a record for the maturity and an increase of $5 billion from the previous week.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Earnings live: AMD, Rivian, Lucid, Snap, and Super Micro Computer stocks fall after quarterly results
Earnings live: AMD, Rivian, Lucid, Snap, and Super Micro Computer stocks fall after quarterly results

Yahoo

time28 minutes ago

  • Yahoo

Earnings live: AMD, Rivian, Lucid, Snap, and Super Micro Computer stocks fall after quarterly results

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive surprises than negative ones. Companies had a lower bar to clear coming into the quarter, as analysts tempered their expectations amid President Trump's tariffs, stocks' lofty valuations, and uncertainty about the health of the US economy. This week, investors will hear from Tyson (TSN), AMD (AMD), Snap (SNAP), McDonald's (MCD), Disney (DIS), Uber (UBER), Lyft (LYFT), Palantir (PLTR), and more when they report results. Data from FactSet published Friday showed that with 66% of the index having reported results, analysts expect S&P 500 companies to report a 10.3% jump in earnings per share during the second quarter. Heading into the quarter, analysts expected S&P 500 earnings to rise 5% in Q2, which would mark the slowest pace of earnings growth since the fourth quarter of 2023. Here are the latest updates from corporate America. Opendoor stock plunges on earnings after meme stock rally Opendoor (OPEN) stock sank precipitously following earnings. Shares of the iBuyer platform, which has become a retail investor darling in recent weeks, dropped as much as 19% despite beats on the top and bottom lines. The stock went on a wild ride in July as retail trader enthusiasm and a thesis from investor and Carvana spotter Eric Jackson bid up shares. Over the past month, Opendoor stock has climbed over 300%. That might be partly why the stock is selling off on the earnings news. The company reported a loss per share of $0.01 for the quarter, compared to estimates for a loss per share of $0.03. Revenue grew 4% annually to $1.6 billion, also above Wall Street analysts' expectations for revenue of $1.5 billion. For the third quarter, Opendoor forecast revenue from $800 million to $875 million. Snap stock drops on weaker-than-expected revenue growth Snap (SNAP) stock declined nearly 15% after Snap reported its slowest revenue growth in more than a year. The Snapchat-parent's net loss in Q2 increased to $263 million from $249 million a year ago. Second quarter revenue rose 8.1% to $1.34 billion, largely in line with estimates. Reuters reports: Read more here. AMD posts mixed Q2 results but offers better than expected Q3 outlook on AI sales Yahoo Finance's Daniel Howley reports: Read more here. Super Micro stock tanks after quarterly revenue miss Super Micro Computer (SMCI) stock plunged 15% after the company's fiscal fourth quarter revenue fell short of estimates amid intense competition for AI server makers. Here's what Super Micro reported against Wall Street consensus estimates compiled by S&P Global Market Intelligence: Lucid misses on both top and bottom lines, trims production forecast Yahoo Finance's Pras Subramanian reports: Read more here. Rivian reports mixed Q2 results, widens 2025 loss projection as tariffs and loss of EV tax credit bite Tariffs and other policies weighed on Rivian's (RIVN) bottom line in the second quarter. For the quarter, Rivian reported a $0.97 loss per share, compared to $0.77 expected, per Bloomberg consensus estimates, with an adjusted EBITDA loss of $667 million versus $493 million expected. The EV maker also did not report a gross profit. Rivian reported revenue of $1.303 billion, compared to $1.28 billion expected and $1.158 billion a year ago. The company also widened its full-year loss projection but increased its EBITDA guidance. Yahoo Finance's Pras Subramanian reports: Read more here. Rivian Q2 earnings preview: EV tax credit impact, R2 SUV update on the agenda Pure-play EV maker Rivian (RIVN) has been building toward profitability, but the loss of federal EV tax credits expiring at the end of September will likely hurt the company's ability to scale up sales. Yahoo Finance's Pras Subramanian previews what to expect when Rivian reports second quarter earnings after the bell on Tuesday: Read more here. Yum Brands stock falls amid underperformance in the US Yum Brands (YUM) stock fell over 3% on Tuesday after an earnings miss and weaker-than-expected sales in the US amid a tougher consumer environment. "Even with a solid overall top line performance, we have opportunities to improve performance in underperforming regions such as the US and parts of Europe, where challenges stem from gaps in value perception, inconsistent consumer experience, and innovation that has not fully resonated with consumers," Yum Brands CEO David Gibbs said on the earnings call. The Taco Bell parent company reported earnings per share of $1.44 adjusted versus $1.46 expected, according to estimates compiled by S&P Global Market Intelligence. Revenue for the quarter hit $1.93 billion, roughly in line with the $1.94 billion expected. US same-store sales for KFC and Pizza Hut fell 5% year over year. US system sales for Taco Bell grew 6%. Lemonade stock jumps on solid guidance Lemonade (LMND) stock jumped 8% in premarket trading as the insurance company kicked off its earnings call and reported a narrower loss than expected. In the second quarter, Lemonade posted a loss of $0.60 per share. Analysts were expecting an $0.80 per share loss. Revenue of $164.1 million beat estimates for $160.8 million and rose 34% from the same period a year ago. Gross profit increased by 109% year on year to $64.3 million, while gross margin improved by 14 points to 39%, the company said. Lemonade also raised its full-year revenue guidance to $710 million-$715 million. Listen to the earnings call here. Caterpillar warns of up to $1.5 billion tariff hit, profit misses on weak demand Caterpillar (CAT) is expecting a bigger hit from tariffs in the third quarter and the rest of 2025 than it initially projected, as President Trump's tariffs hit the industrial and manufacturing segment especially hard. The company flagged a tariff impact of $400 million to $500 million in the third quarter and $1.5 billion hit from costs tied to US tariffs in 2025. Caterpillar was able to offset some of the higher tariff costs; however, higher interest rates and a slowdown in US construction activity led to a pullback in demand for its products. The heavy machinery manufacturer reported adjusted earnings per share of $4.72 on revenue of $16.6 billion. Analysts were expecting adjusted EPS of $4.90 on revenue of $16.3 billion, according to S&P Global Market Intelligence. Caterpillar stock fell less than 1% in premarket trading. Marriott cuts 2025 revenue forecast on soft travel demand Marriott (MAR) signaled it's seeing a slowdown in travel demand amid economic pressures, but more affluent consumers remain more resilient. The hotel chain's adjusted diluted EPS totaled $2.65, compared to estimates of $2.61, according to S&P Global Market Intelligence consensus estimates. Revenue per room increased 1.5% globally during the quarter. For the full year, Marriott forecast room revenue growth of 1.5% to 2.5%, moving its previous higher-end estimate of a 3.5% increase lower. 2025 adjusted profit is expected to be between $9.85 and $10.08 per share, also slightly lower than its earlier projection of $9.82 to $10.19 per share. Reuters reports: Read more here. Pfizer beats Q2 earnings estimates, reaffirms 2025 outlook Pfizer reported an earnings and revenue beat on Tuesday, sending shares higher in premarket trading. For the quarter, Pfizer posted earnings per share of $0.78, versus estimates of $0.58 per share, on revenue of $14.7 billion, compared to Wall Street expectations of $13.5 billion. Yahoo Finance's Anjalee Khemlani reports: Read more here. Mazda forecasts nearly $1 billion profit hit from US tariffs Reuters reports: Read more here. BP vows to do better for investors as profit tops forecast Reuters reports: Read more here. Diageo delivers on annual forecasts, shares jump Reuters reports: Read more here. Dan Ives: Palantir's 'transformational' quarter paves way for $1 trillion market cap Wedbush tech analyst and Palantir (PLTR) bull Dan Ives said he sees the AI software company reaching a trillion-dollar market cap in the next two to three years. "This is transformational, the type of growth they're seeing," Ives said of Palantir's first billion-dollar quarter for revenue, comparing the company to AI-forward Big Tech behemoths like Nvidia (NVDA) and Microsoft (MSFT). "You combine that with what we saw last week from the hyperscalers, that just shows us this AI revolution — it's just started in terms of the next stage of growth," Ives added. Listen to Palantir's earnings call live on the stock page here. Hims & Hers stock tumbles on revenue miss Shares of Hims & Hers (HIMS) slid 11% in after-hours trading following the telehealth company's second quarter results and revenue miss. Earnings came in at $0.17 per share, a slight beat over estimates for $0.16 per share, according to S&P Global Market Intelligence. Second quarter revenue rose 73% year over year, reaching $544.83 million. But it fell short of Wall Street's estimates for $552 million in sales. The company affirmed its full-year guidance of $2.3 billion to $2.4 billion in sales. For the third quarter, it expects $570 million to $590 million in sales. In June, Novo Nordisk (NVO) announced it was terminating an agreement to sell its blockbuster GLP-1 drug Wegovy on the Hims & Hers platform. Investors will be looking to the earnings call for more details on the fallout. Novo Nordisk also cut its sales forecasts for its weight-loss drugs, citing rivals selling compounded versions, such as Hims & Hers. Listen to the earnings call live. Palantir stock surges after company reports first billion-dollar quarter Yahoo Finance's Jake Conley reports: Read more here. Post-earnings stock moves are more volatile than usual this quarter We're two-thirds of the way through earnings season, and for the most part, the market has floated higher on a flurry of earnings releases. Though some individual reports have led to outsized moves. Yahoo Finance's Josh Schafer writes in today's Morning Brief: Read more here. BioNTech shares rise 4% on better-than-expected earnings US-listed shares of the German drugmaker BioNTech (BNTX) rose about 4% in early trading Monday after the company reported better-than-expected second quarter results as it looks to regain momentum after a post-COVID slump. BioNTech reported a loss of 1.60 euros per share, narrower than the 1.69 euro loss analysts expected, according to data from S&P Global Market Intelligence. Revenue of 260.8 million euros ($301 million) fell short of estimates of 263.68 million euros ($304 million). In June, BioNTech announced it would partner with Bristol Myers Squibb (BMY) on a new cancer treatment. "We aim to establish BNT327 both as a new standard of care across multiple tumor types," BioNTech CEO Ugur Sahin said on the company's earnings call. "We are currently advancing BNT327 across more than 10 indications, including two global registrational trials, with more planned. Our early conviction around this modality and BNT327 has put us in a strong position, and if approved, we aim to be the first or second to launch in a number of indications to patients in need." Opendoor stock plunges on earnings after meme stock rally Opendoor (OPEN) stock sank precipitously following earnings. Shares of the iBuyer platform, which has become a retail investor darling in recent weeks, dropped as much as 19% despite beats on the top and bottom lines. The stock went on a wild ride in July as retail trader enthusiasm and a thesis from investor and Carvana spotter Eric Jackson bid up shares. Over the past month, Opendoor stock has climbed over 300%. That might be partly why the stock is selling off on the earnings news. The company reported a loss per share of $0.01 for the quarter, compared to estimates for a loss per share of $0.03. Revenue grew 4% annually to $1.6 billion, also above Wall Street analysts' expectations for revenue of $1.5 billion. For the third quarter, Opendoor forecast revenue from $800 million to $875 million. Opendoor (OPEN) stock sank precipitously following earnings. Shares of the iBuyer platform, which has become a retail investor darling in recent weeks, dropped as much as 19% despite beats on the top and bottom lines. The stock went on a wild ride in July as retail trader enthusiasm and a thesis from investor and Carvana spotter Eric Jackson bid up shares. Over the past month, Opendoor stock has climbed over 300%. That might be partly why the stock is selling off on the earnings news. The company reported a loss per share of $0.01 for the quarter, compared to estimates for a loss per share of $0.03. Revenue grew 4% annually to $1.6 billion, also above Wall Street analysts' expectations for revenue of $1.5 billion. For the third quarter, Opendoor forecast revenue from $800 million to $875 million. Snap stock drops on weaker-than-expected revenue growth Snap (SNAP) stock declined nearly 15% after Snap reported its slowest revenue growth in more than a year. The Snapchat-parent's net loss in Q2 increased to $263 million from $249 million a year ago. Second quarter revenue rose 8.1% to $1.34 billion, largely in line with estimates. Reuters reports: Read more here. Snap (SNAP) stock declined nearly 15% after Snap reported its slowest revenue growth in more than a year. The Snapchat-parent's net loss in Q2 increased to $263 million from $249 million a year ago. Second quarter revenue rose 8.1% to $1.34 billion, largely in line with estimates. Reuters reports: Read more here. AMD posts mixed Q2 results but offers better than expected Q3 outlook on AI sales Yahoo Finance's Daniel Howley reports: Read more here. Yahoo Finance's Daniel Howley reports: Read more here. Super Micro stock tanks after quarterly revenue miss Super Micro Computer (SMCI) stock plunged 15% after the company's fiscal fourth quarter revenue fell short of estimates amid intense competition for AI server makers. Here's what Super Micro reported against Wall Street consensus estimates compiled by S&P Global Market Intelligence: Super Micro Computer (SMCI) stock plunged 15% after the company's fiscal fourth quarter revenue fell short of estimates amid intense competition for AI server makers. Here's what Super Micro reported against Wall Street consensus estimates compiled by S&P Global Market Intelligence: Lucid misses on both top and bottom lines, trims production forecast Yahoo Finance's Pras Subramanian reports: Read more here. Yahoo Finance's Pras Subramanian reports: Read more here. Rivian reports mixed Q2 results, widens 2025 loss projection as tariffs and loss of EV tax credit bite Tariffs and other policies weighed on Rivian's (RIVN) bottom line in the second quarter. For the quarter, Rivian reported a $0.97 loss per share, compared to $0.77 expected, per Bloomberg consensus estimates, with an adjusted EBITDA loss of $667 million versus $493 million expected. The EV maker also did not report a gross profit. Rivian reported revenue of $1.303 billion, compared to $1.28 billion expected and $1.158 billion a year ago. The company also widened its full-year loss projection but increased its EBITDA guidance. Yahoo Finance's Pras Subramanian reports: Read more here. Tariffs and other policies weighed on Rivian's (RIVN) bottom line in the second quarter. For the quarter, Rivian reported a $0.97 loss per share, compared to $0.77 expected, per Bloomberg consensus estimates, with an adjusted EBITDA loss of $667 million versus $493 million expected. The EV maker also did not report a gross profit. Rivian reported revenue of $1.303 billion, compared to $1.28 billion expected and $1.158 billion a year ago. The company also widened its full-year loss projection but increased its EBITDA guidance. Yahoo Finance's Pras Subramanian reports: Read more here. Rivian Q2 earnings preview: EV tax credit impact, R2 SUV update on the agenda Pure-play EV maker Rivian (RIVN) has been building toward profitability, but the loss of federal EV tax credits expiring at the end of September will likely hurt the company's ability to scale up sales. Yahoo Finance's Pras Subramanian previews what to expect when Rivian reports second quarter earnings after the bell on Tuesday: Read more here. Pure-play EV maker Rivian (RIVN) has been building toward profitability, but the loss of federal EV tax credits expiring at the end of September will likely hurt the company's ability to scale up sales. Yahoo Finance's Pras Subramanian previews what to expect when Rivian reports second quarter earnings after the bell on Tuesday: Read more here. Yum Brands stock falls amid underperformance in the US Yum Brands (YUM) stock fell over 3% on Tuesday after an earnings miss and weaker-than-expected sales in the US amid a tougher consumer environment. "Even with a solid overall top line performance, we have opportunities to improve performance in underperforming regions such as the US and parts of Europe, where challenges stem from gaps in value perception, inconsistent consumer experience, and innovation that has not fully resonated with consumers," Yum Brands CEO David Gibbs said on the earnings call. The Taco Bell parent company reported earnings per share of $1.44 adjusted versus $1.46 expected, according to estimates compiled by S&P Global Market Intelligence. Revenue for the quarter hit $1.93 billion, roughly in line with the $1.94 billion expected. US same-store sales for KFC and Pizza Hut fell 5% year over year. US system sales for Taco Bell grew 6%. Yum Brands (YUM) stock fell over 3% on Tuesday after an earnings miss and weaker-than-expected sales in the US amid a tougher consumer environment. "Even with a solid overall top line performance, we have opportunities to improve performance in underperforming regions such as the US and parts of Europe, where challenges stem from gaps in value perception, inconsistent consumer experience, and innovation that has not fully resonated with consumers," Yum Brands CEO David Gibbs said on the earnings call. The Taco Bell parent company reported earnings per share of $1.44 adjusted versus $1.46 expected, according to estimates compiled by S&P Global Market Intelligence. Revenue for the quarter hit $1.93 billion, roughly in line with the $1.94 billion expected. US same-store sales for KFC and Pizza Hut fell 5% year over year. US system sales for Taco Bell grew 6%. Lemonade stock jumps on solid guidance Lemonade (LMND) stock jumped 8% in premarket trading as the insurance company kicked off its earnings call and reported a narrower loss than expected. In the second quarter, Lemonade posted a loss of $0.60 per share. Analysts were expecting an $0.80 per share loss. Revenue of $164.1 million beat estimates for $160.8 million and rose 34% from the same period a year ago. Gross profit increased by 109% year on year to $64.3 million, while gross margin improved by 14 points to 39%, the company said. Lemonade also raised its full-year revenue guidance to $710 million-$715 million. Listen to the earnings call here. Lemonade (LMND) stock jumped 8% in premarket trading as the insurance company kicked off its earnings call and reported a narrower loss than expected. In the second quarter, Lemonade posted a loss of $0.60 per share. Analysts were expecting an $0.80 per share loss. Revenue of $164.1 million beat estimates for $160.8 million and rose 34% from the same period a year ago. Gross profit increased by 109% year on year to $64.3 million, while gross margin improved by 14 points to 39%, the company said. Lemonade also raised its full-year revenue guidance to $710 million-$715 million. Listen to the earnings call here. Caterpillar warns of up to $1.5 billion tariff hit, profit misses on weak demand Caterpillar (CAT) is expecting a bigger hit from tariffs in the third quarter and the rest of 2025 than it initially projected, as President Trump's tariffs hit the industrial and manufacturing segment especially hard. The company flagged a tariff impact of $400 million to $500 million in the third quarter and $1.5 billion hit from costs tied to US tariffs in 2025. Caterpillar was able to offset some of the higher tariff costs; however, higher interest rates and a slowdown in US construction activity led to a pullback in demand for its products. The heavy machinery manufacturer reported adjusted earnings per share of $4.72 on revenue of $16.6 billion. Analysts were expecting adjusted EPS of $4.90 on revenue of $16.3 billion, according to S&P Global Market Intelligence. Caterpillar stock fell less than 1% in premarket trading. Caterpillar (CAT) is expecting a bigger hit from tariffs in the third quarter and the rest of 2025 than it initially projected, as President Trump's tariffs hit the industrial and manufacturing segment especially hard. The company flagged a tariff impact of $400 million to $500 million in the third quarter and $1.5 billion hit from costs tied to US tariffs in 2025. Caterpillar was able to offset some of the higher tariff costs; however, higher interest rates and a slowdown in US construction activity led to a pullback in demand for its products. The heavy machinery manufacturer reported adjusted earnings per share of $4.72 on revenue of $16.6 billion. Analysts were expecting adjusted EPS of $4.90 on revenue of $16.3 billion, according to S&P Global Market Intelligence. Caterpillar stock fell less than 1% in premarket trading. Marriott cuts 2025 revenue forecast on soft travel demand Marriott (MAR) signaled it's seeing a slowdown in travel demand amid economic pressures, but more affluent consumers remain more resilient. The hotel chain's adjusted diluted EPS totaled $2.65, compared to estimates of $2.61, according to S&P Global Market Intelligence consensus estimates. Revenue per room increased 1.5% globally during the quarter. For the full year, Marriott forecast room revenue growth of 1.5% to 2.5%, moving its previous higher-end estimate of a 3.5% increase lower. 2025 adjusted profit is expected to be between $9.85 and $10.08 per share, also slightly lower than its earlier projection of $9.82 to $10.19 per share. Reuters reports: Read more here. Marriott (MAR) signaled it's seeing a slowdown in travel demand amid economic pressures, but more affluent consumers remain more resilient. The hotel chain's adjusted diluted EPS totaled $2.65, compared to estimates of $2.61, according to S&P Global Market Intelligence consensus estimates. Revenue per room increased 1.5% globally during the quarter. For the full year, Marriott forecast room revenue growth of 1.5% to 2.5%, moving its previous higher-end estimate of a 3.5% increase lower. 2025 adjusted profit is expected to be between $9.85 and $10.08 per share, also slightly lower than its earlier projection of $9.82 to $10.19 per share. Reuters reports: Read more here. Pfizer beats Q2 earnings estimates, reaffirms 2025 outlook Pfizer reported an earnings and revenue beat on Tuesday, sending shares higher in premarket trading. For the quarter, Pfizer posted earnings per share of $0.78, versus estimates of $0.58 per share, on revenue of $14.7 billion, compared to Wall Street expectations of $13.5 billion. Yahoo Finance's Anjalee Khemlani reports: Read more here. Pfizer reported an earnings and revenue beat on Tuesday, sending shares higher in premarket trading. For the quarter, Pfizer posted earnings per share of $0.78, versus estimates of $0.58 per share, on revenue of $14.7 billion, compared to Wall Street expectations of $13.5 billion. Yahoo Finance's Anjalee Khemlani reports: Read more here. Mazda forecasts nearly $1 billion profit hit from US tariffs Reuters reports: Read more here. Reuters reports: Read more here. BP vows to do better for investors as profit tops forecast Reuters reports: Read more here. Reuters reports: Read more here. Diageo delivers on annual forecasts, shares jump Reuters reports: Read more here. Reuters reports: Read more here. Dan Ives: Palantir's 'transformational' quarter paves way for $1 trillion market cap Wedbush tech analyst and Palantir (PLTR) bull Dan Ives said he sees the AI software company reaching a trillion-dollar market cap in the next two to three years. "This is transformational, the type of growth they're seeing," Ives said of Palantir's first billion-dollar quarter for revenue, comparing the company to AI-forward Big Tech behemoths like Nvidia (NVDA) and Microsoft (MSFT). "You combine that with what we saw last week from the hyperscalers, that just shows us this AI revolution — it's just started in terms of the next stage of growth," Ives added. Listen to Palantir's earnings call live on the stock page here. Wedbush tech analyst and Palantir (PLTR) bull Dan Ives said he sees the AI software company reaching a trillion-dollar market cap in the next two to three years. "This is transformational, the type of growth they're seeing," Ives said of Palantir's first billion-dollar quarter for revenue, comparing the company to AI-forward Big Tech behemoths like Nvidia (NVDA) and Microsoft (MSFT). "You combine that with what we saw last week from the hyperscalers, that just shows us this AI revolution — it's just started in terms of the next stage of growth," Ives added. Listen to Palantir's earnings call live on the stock page here. Hims & Hers stock tumbles on revenue miss Shares of Hims & Hers (HIMS) slid 11% in after-hours trading following the telehealth company's second quarter results and revenue miss. Earnings came in at $0.17 per share, a slight beat over estimates for $0.16 per share, according to S&P Global Market Intelligence. Second quarter revenue rose 73% year over year, reaching $544.83 million. But it fell short of Wall Street's estimates for $552 million in sales. The company affirmed its full-year guidance of $2.3 billion to $2.4 billion in sales. For the third quarter, it expects $570 million to $590 million in sales. In June, Novo Nordisk (NVO) announced it was terminating an agreement to sell its blockbuster GLP-1 drug Wegovy on the Hims & Hers platform. Investors will be looking to the earnings call for more details on the fallout. Novo Nordisk also cut its sales forecasts for its weight-loss drugs, citing rivals selling compounded versions, such as Hims & Hers. Listen to the earnings call live. Shares of Hims & Hers (HIMS) slid 11% in after-hours trading following the telehealth company's second quarter results and revenue miss. Earnings came in at $0.17 per share, a slight beat over estimates for $0.16 per share, according to S&P Global Market Intelligence. Second quarter revenue rose 73% year over year, reaching $544.83 million. But it fell short of Wall Street's estimates for $552 million in sales. The company affirmed its full-year guidance of $2.3 billion to $2.4 billion in sales. For the third quarter, it expects $570 million to $590 million in sales. In June, Novo Nordisk (NVO) announced it was terminating an agreement to sell its blockbuster GLP-1 drug Wegovy on the Hims & Hers platform. Investors will be looking to the earnings call for more details on the fallout. Novo Nordisk also cut its sales forecasts for its weight-loss drugs, citing rivals selling compounded versions, such as Hims & Hers. Listen to the earnings call live. Palantir stock surges after company reports first billion-dollar quarter Yahoo Finance's Jake Conley reports: Read more here. Yahoo Finance's Jake Conley reports: Read more here. Post-earnings stock moves are more volatile than usual this quarter We're two-thirds of the way through earnings season, and for the most part, the market has floated higher on a flurry of earnings releases. Though some individual reports have led to outsized moves. Yahoo Finance's Josh Schafer writes in today's Morning Brief: Read more here. We're two-thirds of the way through earnings season, and for the most part, the market has floated higher on a flurry of earnings releases. Though some individual reports have led to outsized moves. Yahoo Finance's Josh Schafer writes in today's Morning Brief: Read more here. BioNTech shares rise 4% on better-than-expected earnings US-listed shares of the German drugmaker BioNTech (BNTX) rose about 4% in early trading Monday after the company reported better-than-expected second quarter results as it looks to regain momentum after a post-COVID slump. BioNTech reported a loss of 1.60 euros per share, narrower than the 1.69 euro loss analysts expected, according to data from S&P Global Market Intelligence. Revenue of 260.8 million euros ($301 million) fell short of estimates of 263.68 million euros ($304 million). In June, BioNTech announced it would partner with Bristol Myers Squibb (BMY) on a new cancer treatment. "We aim to establish BNT327 both as a new standard of care across multiple tumor types," BioNTech CEO Ugur Sahin said on the company's earnings call. "We are currently advancing BNT327 across more than 10 indications, including two global registrational trials, with more planned. Our early conviction around this modality and BNT327 has put us in a strong position, and if approved, we aim to be the first or second to launch in a number of indications to patients in need." US-listed shares of the German drugmaker BioNTech (BNTX) rose about 4% in early trading Monday after the company reported better-than-expected second quarter results as it looks to regain momentum after a post-COVID slump. BioNTech reported a loss of 1.60 euros per share, narrower than the 1.69 euro loss analysts expected, according to data from S&P Global Market Intelligence. Revenue of 260.8 million euros ($301 million) fell short of estimates of 263.68 million euros ($304 million). In June, BioNTech announced it would partner with Bristol Myers Squibb (BMY) on a new cancer treatment. "We aim to establish BNT327 both as a new standard of care across multiple tumor types," BioNTech CEO Ugur Sahin said on the company's earnings call. "We are currently advancing BNT327 across more than 10 indications, including two global registrational trials, with more planned. Our early conviction around this modality and BNT327 has put us in a strong position, and if approved, we aim to be the first or second to launch in a number of indications to patients in need." Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Marriott Lowers Full-Year Outlook
Marriott Lowers Full-Year Outlook

Skift

time29 minutes ago

  • Skift

Marriott Lowers Full-Year Outlook

The DJIA fell 62 points while the Nasdaq was down 137, the S&P 500 fell 31 points, and the 10-year treasury yield was flat at 4.20%. Lodging stocks were modestly lower. On the earnings side, out of the three that reported, the one with the best report, VAC, was the only one in negative territory, as MAR and RHP both squeaked out gains on the day. SVC was the biggest mover in the group, up 5%. Marriott International beat second-quarter expectations but did what most of the others have not been doing: lowered the 2025 RevPAR outlook. They also lowered 2025 adjusted EBITDA guidance slightly, with the cut being for a weaker-than-expected 3Q as MAR expects an acceleration in 4Q. MAR repurchased 2.8 million shares in 2Q for $700 million. MAR expects to return $4 billion in capital to shareholders for the year with share repurchases and dividends. Ryman Hospitality Properties reported better-than-expected 2Q25 results but cut net income

‘Open-weight' debate: Allen Institute for AI says OpenAI needs to go further to be truly open
‘Open-weight' debate: Allen Institute for AI says OpenAI needs to go further to be truly open

Geek Wire

time29 minutes ago

  • Geek Wire

‘Open-weight' debate: Allen Institute for AI says OpenAI needs to go further to be truly open

OLMo leader Hanna Hajishirzi of AI2 and the University of Washington delivers the luncheon keynote in 2023 during an event at the UW's Paul G. Allen School of Computer Science & Engineering. (GeekWire File Photo / Todd Bishop) OpenAI's new models may be 'open-weight,' but a leading artificial intelligence research institute says they aren't nearly open enough, asserting that the release highlights the ongoing question of what transparency in AI really means. That's the view of Hanna Hajishirzi, senior director of AI at the Seattle-based Allen Institute for AI (AI2) and a professor at the University of Washington. In a statement after OpenAI's announcement, Hajishirzi said AI2 is 'excited to see OpenAI has joined the efforts to release more 'open source' models,' but added that the move 'brings into focus the unresolved debate over what constitutes meaningful openness in AI.' 'At Ai2, we believe that meaningful progress in AI is best achieved in the open — not just with open weights, but with open data, transparent training methods, intermediate checkpoints from pre-training and mid-training, and shared evaluations,' she stated. For its part, OpenAI did release significant details about the models' architecture, including that they are transformers that use a Mixture-of-Experts (MoE) framework to reduce the number of active parameters needed for processing. The company also provided specifics on the models' layers, total and active parameters, and the number of experts. However, on the subject of training data, OpenAI did not release its proprietary dataset, noting only that it had a 'focus on STEM, coding, and general knowledge.' This contrasts with AI2's call for open data as a key pillar of transparency. OpenAI's announcement did highlight a specific commitment to transparency in one area: the model's reasoning process. The company said it intentionally avoided direct supervision of the model's 'chain-of-thought' (CoT) process to allow researchers to better monitor for misuse and deception. OpenAI stated its hope is that this 'gives developers and researchers the opportunity to research and implement their own CoT monitoring systems.' OpenAI also announced it is hosting a $500,000 Red Teaming Challenge to encourage researchers to find novel safety issues. The company said it will 'open-source an evaluation data set based on validated findings, so that the wider community can immediately benefit.' In the U.S., Facebook parent Meta has championed open-weight models since releasing the first of its Llama series in 2023. However, CEO Mark Zuckerberg has signaled the company may move away from open-source for future models, citing potential safety concerns. The competitive landscape for open-weight models was also shaken up earlier this year when the Chinese startup DeepSeek stunned Silicon Valley with the release of its open-weight AI technology, demonstrating the effectiveness of cheaper AI models. Ai2's Hajishirzi contrasted OpenAI's release with AI2's own fully open models, like OLMo, which include tools that provide full visibility into their training data. Hajishirzi called this a 'pivotal moment for the industry to align on deeper, more verifiable standards of openness that foster collaboration, accelerate innovation, and expand access for everyone.' She added, 'Now more than ever, we must rethink how AI is developed – where transparency, reproduciblity, and broad access are essential to form the foundation for sustainable innovation, public trust, and global competitiveness in AI.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store